Drugs / umbilical cord-derived mesenchymal stem cells conditioned medium
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05887804 | Oct 2021 → Jun 2022 | keloid | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Completed | No outcome recorded |
| Phase 4 | NCT05939817 | Oct 2021 → Jun 2022 | keloid | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord-derived mesenchymal stem cells conditioned medium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05939817 ↗ |
| Known as | UC-CM | “umbilical cord-derived mesenchymal stem cells conditioned medium (UC-CM)” NCT05887804 ↗1“umbilical cord-derived mesenchymal stem cells conditioned medium (UC-CM)” NCT05939817 ↗ |
| Route | Other | “intralesional injection” NCT05887804 ↗ |